Oxford BioMedica PLC Cash Flow Reinvestment Rate
Oxford BioMedica PLC cash flow reinvestment rate. Oxford BioMedica PLC (OXB) has a Cash Flow Reinvestment Rate of 0.64x as of June 2025, reinvesting GBX1.51 Million (capex GBX1.51 Million ) from operating cash flow of GBX2.35 Million. See OXB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Oxford BioMedica PLC (2007–2021)
Cash flow reinvestment rate of Oxford BioMedica PLC from 2007 to 2021. Historical reinvestment intensity for Oxford BioMedica PLC across 6 annual periods. Explore OXB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Oxford BioMedica PLC Cash Flow Reinvestment Rate by Year (2007–2021)
Oxford BioMedica PLC cash flow reinvestment rate by year from 2007 to 2021. Year-by-year capital reinvestment analysis for Oxford BioMedica PLC. For the full cash flow conversion analysis, see Oxford BioMedica PLC operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.74x | GBX18.92 Million | GBX25.45 Million | GBX9.46 Million | ▼ -85.4% |
| 2020 | 5.10x | GBX15.88 Million | GBX3.12 Million | GBX13.36 Million | ▲ +299.5% |
| 2018 | 1.28x | GBX16.42 Million | GBX12.87 Million | GBX10.15 Million | ▼ -53.9% |
| 2017 | 2.77x | GBX8.24 Million | GBX2.98 Million | GBX1.97 Million | ▲ +2122.2% |
| 2009 | 0.12x | GBX288.00K | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX421.00K | GBX4.73 Million | GBX421.00K | — |